Serum S100B in primary progressive multiple sclerosis patients treated with interferon-beta-1a

Overview of attention for article published in Journal of Negative Results in BioMedicine, October 2004

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#28 of 113)
High Attention Score compared to outputs of the same age (83rd percentile)

Mentioned by

blogs: 1 blog

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 25 Mendeley

Summary Blogs Dimensions citations

So far, Altmetric has seen 1 blog post.

Good Pharma?

Multiple Sclerosis Research, 06 Nov 2012

For those you following the Good Pharma - Bad Pharma debate may find last week's BMJ Editorial by Fiona Godlee interesting:Fiona…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.